Long survival of patients with unresectable cervical carcinoma after radiotherapy

Japanese Journal of Clinical Oncology

Volumn 27, Issue 4, 1997, Pages 285-287

  Sakata, Koh Ichi ^a,b   Hareyama, Masato ^a   Yama, Naoya ^a   Oouchi, Atsushi ^a   Shido, Mitsuo ^a   Nagakura, Hisayasu ^a   Morita, Kazuo ^a   Kudo, Ryuichi ^b  

^a Department of Radiology ^*  (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Carcinoma; Exploratory laparotomy; Radiotherapy; Unresectable tumor; Uterine cervix

Indexed keywords

CESIUM; COBALT; RADIOPHARMACEUTICAL AGENT;

AGED; ANAL CANAL; ARTICLE; BLADDER; BRACHYTHERAPY; CANCER INVASION; CANCER STAGING; CASE REPORT; CAUSE OF DEATH; FATALITY; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HUMAN; INTESTINE OBSTRUCTION; LAPAROTOMY; LYMPH NODE METASTASIS; METASTASIS; MIDDLE AGED; PATHOLOGY; SMALL INTESTINE; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TUMOR RECURRENCE; UTERINE CERVIX TUMOR;

AGED; ANAL CANAL; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; CAUSE OF DEATH; CESIUM RADIOISOTOPES; COBALT RADIOISOTOPES; FATAL OUTCOME; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HUMANS; INTESTINAL OBSTRUCTION; INTESTINE, SMALL; LAPAROTOMY; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOPHARMACEUTICALS; SURVIVAL RATE; URINARY BLADDER; UTERINE CERVICAL NEOPLASMS;

EID: 0031205326     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/27.4.285     Document Type: Article

References (15)

1. International Federation of Gynecologists and Obstetricians (FIGO) Changes in the definitions of clinical staging for the cervix and ovary. Am. J. Obstet. Gynecol. 1987;56:263-4.
2. Perez, CA. Uterine Cervix. In: Principles and Practice of Radiation Oncology, 2nd ed. Perez, CA, Brady, LW, editors. Philadelphia: JB Lippincott, 1992; 1143-202.
3. Sato, H. Fujikawa, K. Azuma, T, Akiya, K. Multidisciplinary, intra-arterial chemotherapy with CDDP and 5-FU against cervical cancer. Gan To Kagaku-Ryoho 1988;15:2443-7 (in Japanese).
4. Grigsby, PW, Perez, CA, Kuske, RR, Camel, HM, Kao, MS, Galakatos et al. Adenocarcinoma of the uterine cervix, lack of evidence for a poor prognosis. Radiother Oncol 1988;12:289-96.
5. Potish, RA, Downey, GO, Adcock, LL, Prem, KA, Twiggs, LB. The role of surgical debulking in cancer of the uterine cervix. Int J Radiat Oncol Biol Phys 1989;17:979-84.
6. Wharton JT, Jones HW, Day TG, Rutledge FN, Fletcher GH. Preirradiation celiotomy and extended field irradiation for invasive carcinoma of the cervix. Obstet Gynecol 1976;49:333-8.
7. Piver MS, Barlow JJ, Krishnamsetty R. Five-year survival (with no evidence of disease) in patients with biopsy-confirmed aortic node metastasis from cervical carcinoma. Am J Obstet Gynecol 1981;139:575-8.
8. Coia L, Won M, Lanciano R, Marcial VA, Martz K, Hanks G. The patterns of care outcome study for cancer of the uterine cervix. Cancer 1990;66:2451-6.
9. Berman ML, Lagasse LD, Warring WG, Ballon SC, Schlesinger RE, Moore JG et al. The operative evaluation of patients with cervical carcinoma by an extraperitoneal approach. Obstet Gynecol 1977;50:658-64.
10. LaPolla JP, Schlaerth JB, Caddis O, Morrow CP. The influence of surgical staging on the evaluation and treatment of patients with cervical carcinoma. Gynecol Oncol 1986;24:194-206.
11. Andras E, Fletcher GH, Rutledge F. Radiotherapy of carcinoma of the cervix following simple hysterectomy Am J Obstet Gynecol 1973;115:647-55.
12. Rutledge JT, Fletcher GH, Macdonald EJ. Pelvic lymphadenectomy as an adjunct to radiation therapy in treatment for cancer of the cervix. Am J Roentgenol 1965;93:607-14.
13. Fletcher GH Subclinical disease. Cancer 1984;55:1274-84.
14. Nelson JH, Boyce J, Macasaet M, Lu T, Bohorquez JF, Nicastri AD et al. Incidence, significance and follow-up of para-aortic lymph node metastases in late invasive carcinoma of the cervix. Am J Obstet Gynecol 1977;128: 336-40.
15. Haie C, Pejovic MH, Gerbaulet A Horiot JC, Pourquier H, Delouche J et al Is prophylactic paraaortic irradiation worthwhile in the treatment of advanced cervical carcinoma? Results of a controlled clinical trial of the EORTC radiotherapy group. Radiother Oncol 1988;11:101-12.